DICE

Why Is Dice Therapeutics (DICE) Stock Up 38% Today?

By William White, InvestorPlace Writer
Dice Therapeutics (DICE) stock is surging higher on Tuesday after Eli Lilly (LLY) announced plans to acquire the biopharmaceutical company.

What Is Going on With DICE Therapeutics (DICE) Stock?

By Joel Baglole, InvestorPlace Contributor
Shares of DICE stock are up an astounding 50% today on news of a positive clinical trial related to the Dice's psoriasis treatment.